Citadel Advisors’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Citadel Advisors’s Portfolio RCPI Stock Details RCPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-6,600	Closed	-$5K	–	9758
2015 Q3	$5K	Sell	6,600 -3,100	-32%	-$3.45K	﹤0.01%	8656
2015 Q2	$15K	Buy	+9,700	New	+$23.1K	﹤0.01%	8300
2015 Q1	–	Sell	-504	Closed	-$2K	–	9206
2014 Q4	$2K	Buy	504 +80	+19%	+$421	﹤0.01%	8401
2014 Q3	$3K	Sell	424 -228	-35%	-$2.25K	﹤0.01%	7984
2014 Q2	$10K	Buy	+652	New	+$11.3K	﹤0.01%	7592

Other funds holding RCPI

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

KCM

Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return

WealthPLAN Partners Omaha, Nebraska $523M AUM 23.92% 1-Year Est. Return

IWMPD

Integrated Wealth Management (Palm Desert) Palm Desert, California $299M AUM 12.85% 1-Year Est. Return

Citadel Advisors's RCPI Position: Q4 2015 in Review

Citadel Advisors sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q4 2015, closing a stake of 30,559 shares — an estimated $25K sold.

Citadel Advisors first reported a position in RCPI in Q2 2014 and held it in 5 quarters. The position peaked at $26K in Q2 2014. 9 funds tracked by Wall St. Rank hold RCPI as of Q4 2015.

Citadel Advisors reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
Citadel Advisors sold 30,559 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q4 2015, an estimated $25K.
Citadel Advisors first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 5 quarters.
Citadel Advisors's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $26K in Q2 2014.
9 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q4 2015.

Based on Citadel Advisors's 13F filing for Q4 2015, filed 12 Feb 2016.